1 Oct 2021

Boston Scientific to Invest €30 Million in the Research, Development, and Innovative Capabilities of Cork Facility

Boston Scientific Corporation has announced a €30 million investment for its Cork facility further enhancing Cork’s profile as a world-renowned location for research, development, and innovation.

Boston Scientific first established its Irish footprint in 1994 and today is the largest life sciences employer in Ireland. With a workforce of more than 6,000 people across three locations at Galway, Clonmel and Cork, the company exports more than 12 million medical devices annually.

The €30 million investment will further enhance the development and manufacturing of minimally invasive medical technologies which are most commonly used to treat patients who suffer from cancer and peripheral arterial diseases.

This investment in research, development and innovation is supported by the Irish government through IDA and will further diversify the range of technologies developed and manufactured at Boston Scientific’s Cork site where over 1,200 people are currently employed. The investment is expected to generate 70 new quality, engineering and production jobs over the next 3 years.

Tánaiste and Minister for Enterprise, Trade and Employment Leo Varadkar TD said:

“I am pleased that the Boston Scientific Corporation has announced this significant €30 million investment in its Cork facility,”

“This investment will allow the company to grow and develop its world-leading technologies and ensure that it continues helping to improve and save lives. Ireland is globally recognised as a centre of excellence for the Life Sciences and this investment is a real vote of confidence in us and our capacity. I wish the team the very best with their plans.”

Martin Shanahan, CEO, IDA Ireland said:

“Boston Scientific has had a strong presence in the Cork business community for nearly 25 years.”

“As the company grows and expands into more therapeutic areas through internal RD&I and acquisitions its continued investment in ongoing operations and highly skilled local talent is encouraging. This expansion is further evidence of the southwest region’s thriving MedTech cluster.

IDA Ireland is tasked with attracting investment into Ireland by foreign-owned companies with a focus on jobs growth and industrial transformation in high growth sectors including MedTech. Today, Ireland has the highest per capita number of people employed in the European medical device industry. The agency supports a wide range of multinational companies with operations in Ireland through grants and other business supports in compliance with EU and Irish legislation.

Sean Gayer, vice president of operations at Boston Scientific, Cork, said:

“We are delighted to be adding new quality, engineering and production capabilities to our Cork facility and contributing further to the strong MedTech sector in the region,”

“We appreciate the Irish Government support through IDA Ireland.”